A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation
Abstract
:1. Introduction
2. Results and Discussion
2.1. Biopanning for Cu(II)-Binding Peptides and Peptide Sequence Analysis
2.2. Selection of Candidate Peptide Binding to Cu(II)
2.3. Inhibition of Cu2+-Mediated Aβ1-42 Aggregation by PCu In Vitro
2.4. PCu Attenuated Cu2+-Mediated Cell Damage and Oxidative Stress
2.5. PCu Inhibited Cu2+-Mediated Aβ Deposition In Vitro
2.6. PCu Enters the Brain after Intranasal Administration
3. Materials and Methods
3.1. Thioflavin T Assays
3.2. Transmission Electron Microscopy
3.3. Cells
3.4. ELISA-Based Measurement of Aβ Level
3.5. Immunofluorescence Staining
3.6. Copper Analysis with Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
3.7. Western Blot Analysis
3.8. Animal Imaging Analysis
3.9. Statistical Analysis
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Long, J.M.; Holtzman, D.M. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 2019, 179, 312–339. [Google Scholar] [CrossRef]
- Zhang, X.; Zhang, X.; Zhong, M.; Zhao, P.; Guo, C.; Li, Y.; Wang, T.; Gao, H. Selection of a d-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice. ACS Chem. Neurosci. 2020, 11, 4240–4253. [Google Scholar] [CrossRef] [PubMed]
- Haass, C.; Kaether, C.; Thinakaran, G.; Sisodia, S. Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect. Med. 2012, 2, a006270. [Google Scholar] [CrossRef]
- Karran, E.; Mercken, M.; De Strooper, B. The amyloid cascade hypothesis for Alzheimer’s disease: An appraisal for the development of therapeutics. Nature reviews. Drug Discov. 2011, 10, 698–712. [Google Scholar] [CrossRef] [PubMed]
- Haass, C.; Selkoe, D.J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid beta-peptide. Nature reviews. Mol. Cell Biol. 2007, 8, 101–112. [Google Scholar] [CrossRef]
- Kuperstein, I.; Broersen, K.; Benilova, I.; Rozenski, J.; Jonckheere, W.; Debulpaep, M.; Vandersteen, A.; Segers-Nolten, I.; Van Der Werf, K.; Subramaniam, V.; et al. Neurotoxicity of Alzheimer’s disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 2010, 29, 3408–3420. [Google Scholar] [CrossRef] [PubMed]
- Pauwels, K.; Williams, T.L.; Morris, K.L.; Jonckheere, W.; Vandersteen, A.; Kelly, G.; Schymkowitz, J.; Rousseau, F.; Pastore, A.; Serpell, L.C.; et al. Structural basis for increased toxicity of pathological abeta42:abeta40 ratios in Alzheimer disease. J. Biol. Chem. 2012, 287, 5650–5660. [Google Scholar] [CrossRef] [Green Version]
- Jia, Z.; Schmit, J.D.; Chen, J. Amyloid assembly is dominated by misregistered kinetic traps on an unbiased energy landscape. Proc. Natl. Acad. Sci. USA 2020, 117, 10322–10328. [Google Scholar] [CrossRef] [PubMed]
- Singh, V.; Xu, L.; Boyko, S.; Surewicz, K.; Surewicz, W.K. Zinc promotes liquid-liquid phase separation of tau protein. J. Biol. Chem. 2020, 295, 5850–5856. [Google Scholar] [CrossRef] [Green Version]
- Zhong, M.; Kou, H.; Zhao, P.; Zheng, W.; Xu, H.; Zhang, X.; Lan, W.; Guo, C.; Wang, T.; Guo, F.; et al. Nasal Delivery of D-Penicillamine Hydrogel Upregulates a Disintegrin and Metalloprotease 10 Expression via Melatonin Receptor 1 in Alzheimer’s Disease Models. Front. Aging Neurosci. 2021, 13, 660249. [Google Scholar] [CrossRef]
- Rossi, L.; Squitti, R.; Pasqualetti, P.; Marchese, E.; Cassetta, E.; Forastiere, E.; Rotilio, G.; Rossini, P.M.; Finazzi-Agró, A. Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer’s disease and is decreased by D-penicillamine. Neurosci. Lett. 2002, 329, 137–140. [Google Scholar] [CrossRef]
- Cuajungco, M.P.; Fagét, K.Y.; Huang, X.; Tanzi, R.E.; Bush, A.I. Metal chelation as a potential therapy for Alzheimer’s disease. Ann. N. Y. Acad. Sci. 2000, 920, 292–304. [Google Scholar] [CrossRef] [PubMed]
- Lovell, M.A.; Robertson, J.D.; Teesdale, W.J.; Campbell, J.L.; Markesbery, W.R. Copper, iron and zinc in Alzheimer’s disease senile plaques. J. Neurol. Sci. 1998, 158, 47–52. [Google Scholar] [CrossRef]
- Frederickson, C.J.; Koh, J.Y.; Bush, A.I. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 2005, 6, 449–462. [Google Scholar] [CrossRef]
- Huat, T.J.; Camats-Perna, J.; Newcombe, E.A.; Valmas, N.; Kitazawa, M.; Medeiros, R. Metal Toxicity Links to Alzheimer’s Disease and Neuroinflammation. J. Mol. Biol. 2019, 431, 1843–1868. [Google Scholar] [CrossRef]
- Atwood, C.S.; Perry, G.; Zeng, H.; Kato, Y.; Jones, W.D.; Ling, K.Q.; Huang, X.; Moir, R.D.; Wang, D.; Sayre, L.M.; et al. Copper mediates dityrosine cross-linking of Alzheimer’s amyloid-beta. Biochemistry 2004, 43, 560–568. [Google Scholar] [CrossRef]
- Bush, A.I. The metal theory of Alzheimer’s disease. J. Alzheimers Dis. 2013, 33 (Suppl. 1), S277–S281. [Google Scholar] [CrossRef]
- Multhaup, G.; Ruppert, T.; Schlicksupp, A.; Hesse, L.; Bill, E.; Pipkorn, R.; Masters, C.L.; Beyreuther, K. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 1998, 37, 7224–7230. [Google Scholar] [CrossRef]
- Sensi, S.L.; Granzotto, A.; Siotto, M.; Squitti, R. Copper and Zinc Dysregulation in Alzheimer’s Disease. Trends Pharmacol. Sci. 2018, 39, 1049–1063. [Google Scholar] [CrossRef] [PubMed]
- Bakavayev, S.; Chetrit, N.; Zvagelsky, T.; Mansour, R.; Vyazmensky, M.; Barak, Z.; Israelson, A.; Engel, S. Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H(2)O(2) via cysteine-dependent redox short-circuit. Sci. Rep. 2019, 9, 10826. [Google Scholar] [CrossRef] [PubMed]
- Jiang, D.; Men, L.; Wang, J.; Zhang, Y.; Chickenyen, S.; Wang, Y.; Zhou, F. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance. Biochemistry 2007, 46, 9270–9282. [Google Scholar] [CrossRef] [Green Version]
- Ali, F.E.; Separovic, F.; Barrow, C.J.; Cherny, R.A.; Fraser, F.; Bush, A.I.; Masters, C.L.; Barnham, K.J. Methionine regulates copper/hydrogen peroxide oxidation products of Abeta. J. Pept. Sci. Off. Publ. Eur. Pept. Soc. 2005, 11, 353–360. [Google Scholar] [CrossRef] [Green Version]
- Repetto, M.G.; Reides, C.G.; Evelson, P.; Kohan, S.; de Lustig, E.S.; Llesuy, S.F. Peripheral markers of oxidative stress in probable Alzheimer patients. Eur. J. Clin. Investig. 1999, 29, 643–649. [Google Scholar] [CrossRef] [PubMed]
- Tönnies, E.; Trushina, E. Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease. J. Alzheimers Dis. 2017, 57, 1105–1121. [Google Scholar] [CrossRef] [Green Version]
- Iraji, A.; Khoshneviszadeh, M.; Firuzi, O.; Khoshneviszadeh, M.; Edraki, N. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. Bioorg. Chem. 2020, 97, 103649. [Google Scholar] [CrossRef] [PubMed]
- Jokar, S.; Khazaei, S.; Behnammanesh, H.; Shamloo, A.; Erfani, M.; Beiki, D.; Bavi, O. Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy. Biophys. Rev. 2019, 11, 901–925. [Google Scholar] [CrossRef]
- Cherny, R.A.; Atwood, C.S.; Xilinas, M.E.; Gray, D.N.; Jones, W.D.; McLean, C.A.; Barnham, K.J.; Volitakis, I.; Fraser, F.W.; Kim, Y.; et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease transgenic mice. Neuron 2001, 30, 665–676. [Google Scholar] [CrossRef] [Green Version]
- Sestito, S.; Wang, S.; Chen, Q.; Lu, J.; Bertini, S.; Pomelli, C.; Chiellini, G.; He, X.; Pi, R.; Rapposelli, S. Multi-targeted ChEI-copper chelating molecules as neuroprotective agents. Eur. J. Med. Chem. 2019, 174, 216–225. [Google Scholar] [CrossRef]
- Raman, B.; Ban, T.; Yamaguchi, K.; Sakai, M.; Kawai, T.; Naiki, H.; Goto, Y. Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide. J. Biol. Chem. 2005, 280, 16157–16162. [Google Scholar] [CrossRef] [Green Version]
- Di Vaira, M.; Bazzicalupi, C.; Orioli, P.; Messori, L.; Bruni, B.; Zatta, P. Clioquinol, a drug for Alzheimer’s disease specifically interfering with brain metal metabolism: Structural characterization of its zinc(II) and copper(II) complexes. Inorg. Chem. 2004, 43, 3795–3797. [Google Scholar] [CrossRef]
- Cherny, R.A.; Barnham, K.J.; Lynch, T.; Volitakis, I.; Li, Q.X.; McLean, C.A.; Multhaup, G.; Beyreuther, K.; Tanzi, R.E.; Masters, C.L.; et al. Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer’s disease. J. Struct. Biol. 2000, 130, 209–216. [Google Scholar] [CrossRef]
- Wang, C.Y.; Xie, J.W.; Xu, Y.; Wang, T.; Cai, J.H.; Wang, X.; Zhao, B.L.; An, L.; Wang, Z.Y. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer’s disease. Antioxid. Redox Signal. 2013, 19, 2024–2039. [Google Scholar] [CrossRef] [Green Version]
- Zhang, X.; Zhong, M.; Zhao, P.; Zhang, X.; Li, Y.; Wang, X.; Sun, J.; Lan, W.; Sun, H.; Wang, Z.; et al. Screening a specific Zn(ii)-binding peptide for improving the cognitive decline of Alzheimer’s disease in APP/PS1 transgenic mice by inhibiting Zn(2+)-mediated amyloid protein aggregation and neurotoxicity. Biomater. Sci. 2019, 7, 5197–5210. [Google Scholar] [CrossRef] [PubMed]
- Szardenings, M.; Muceniece, R.; Mutule, I.; Mutulis, F.; Wikberg, J.E. New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 2000, 21, 239–243. [Google Scholar] [CrossRef]
- Ishii, H.; Zahra, M.H.; Takayanagi, A.; Seno, M. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth. Int. J. Mol. Sci. 2021, 22, 1709. [Google Scholar] [CrossRef] [PubMed]
- Yang, T.; Zhang, X.Y.; Zhang, X.X.; Chen, M.L.; Wang, J.H. Chromium(III) Binding Phage Screening for the Selective Adsorption of Cr(III) and Chromium Speciation. ACS Appl. Mater. Interfaces 2015, 7, 21287–21294. [Google Scholar] [CrossRef]
- Yang, T.; Zhang, X.X.; Yang, J.Y.; Wang, Y.T.; Chen, M.L. Screening arsenic(III)-binding peptide for colorimetric detection of arsenic(III) based on the peptide induced aggregation of gold nanoparticles. Talanta 2018, 177, 212–216. [Google Scholar] [CrossRef]
- Wang, X.Y.; Yang, J.Y.; Wang, Y.T.; Zhang, H.C.; Chen, M.L.; Yang, T.; Wang, J.H. M13 phage-based nanoprobe for SERS detection and inactivation of Staphylococcus aureus. Talanta 2021, 221, 121668. [Google Scholar] [CrossRef] [PubMed]
- Matsubara, T.; Hiura, Y.; Kawahito, O.; Yasuzawa, M.; Kawashiro, K. Selection of novel structural zinc sites from a random peptide library. FEBS Lett. 2003, 555, 317–321. [Google Scholar] [CrossRef]
- Kotrba, P.; Doleckova, L.; De Lorenzo, V.; Ruml, T. Enhanced bioaccumulation of heavy metal ions by bacterial cells due to surface display of short metal binding peptides. Appl. Environ. Microbiol. 1999, 65, 1092–1098. [Google Scholar] [CrossRef] [Green Version]
- Samuelson, P.; Wernerus, H.; Svedberg, M.; Stahl, S. Staphylococcal surface display of metal-binding polyhistidyl peptides. Appl. Environ. Microbiol. 2000, 66, 1243–1248. [Google Scholar] [CrossRef] [Green Version]
- Patwardhan, A.V.; Goud, G.N.; Koepsel, R.R.; Ataai, M.M. Selection of optimum affinity tags from a phage-displayed peptide library—Application to immobilized copper(II) affinity chromatography. J. Chromatogr. A 1997, 787, 91–100. [Google Scholar] [CrossRef]
- Arispe, N.; Diaz, J.C.; Flora, M. Efficiency of Histidine-Associating Compounds for Blocking the Alzheimer’s A beta Channel Activity and Cytotoxicity. Biophys. J. 2008, 95, 4879–4889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Smith, D.P.; Smith, D.G.; Curtain, C.C.; Boas, J.F.; Pilbrow, J.R.; Ciccotosto, G.D.; Lau, T.L.; Tew, D.J.; Perez, K.; Wade, J.D.; et al. Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge. J. Biol. Chem. 2006, 281, 15145–15154. [Google Scholar] [CrossRef] [Green Version]
- McGowan, E.; Pickford, F.; Kim, J.; Onstead, L.; Eriksen, J.; Yu, C.; Skipper, L.; Murphy, M.P.; Beard, J.; Das, P.; et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005, 47, 191–199. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dong, J.; Atwood, C.S.; Anderson, V.E.; Siedlak, S.L.; Smith, M.A.; Perry, G.; Carey, P.R. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 2003, 42, 2768–2773. [Google Scholar] [CrossRef] [PubMed]
- LeVine, H., 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309, 274–284. [Google Scholar] [CrossRef]
- Wang, X.; Wang, C.L.; Chu, H.Y.; Qin, H.J.; Wang, D.D.; Xu, F.F.; Ai, X.J.; Quan, C.S.; Li, G.H.; Qing, G.Y. Molecular chirality mediated amyloid formation on phospholipid surfaces. Chem. Sci. 2020, 11, 7369–7378. [Google Scholar] [CrossRef]
- Sharma, A.K.; Pavlova, S.T.; Kim, J.; Kim, J.; Mirica, L.M. The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity. Metallomics 2013, 5, 1529–1536. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zou, J.; Kajita, K.; Sugimoto, N. Cu(2+) Inhibits the Aggregation of Amyloid β-Peptide(1-42) in vitro. Angew. Chem. Int. Ed. Engl. 2001, 40, 2274–2277. [Google Scholar] [CrossRef]
- Bazhin, A.A.; Sinisi, R.; De Marchi, U.; Hermant, A.; Sambiagio, N.; Maric, T.; Budin, G.; Goun, E.A. A bioluminescent probe for longitudinal monitoring of mitochondrial membrane potential. Nat. Chem. Biol. 2020, 16, 1385–1393. [Google Scholar] [CrossRef]
- Perelman, A.; Wachtel, C.; Cohen, M.; Haupt, S.; Shapiro, H.; Tzur, A. JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 2012, 3, e430. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Keil, V.C.; Funke, F.; Zeug, A.; Schild, D.; Müller, M. Ratiometric high-resolution imaging of JC-1 fluorescence reveals the subcellular heterogeneity of astrocytic mitochondria. Pflug. Arch. Eur. J. Physiol. 2011, 462, 693–708. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheignon, C.; Tomas, M.; Bonnefont-Rousselot, D.; Faller, P.; Hureau, C.; Collin, F. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2018, 14, 450–464. [Google Scholar] [CrossRef]
- Dikalov, S.I.; Vitek, M.P.; Mason, R.P. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radic. Biol. Med. 2004, 36, 340–347. [Google Scholar] [CrossRef]
- Guilloreau, L.; Combalbert, S.; Sournia-Saquet, A.; Mazarguil, H.; Faller, P. Redox chemistry of copper-amyloid-beta: The generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state. Chembiochem 2007, 8, 1317–1325. [Google Scholar] [CrossRef] [PubMed]
- Angeletti, B.; Waldron, K.J.; Freeman, K.B.; Bawagan, H.; Hussain, I.; Miller, C.C.; Lau, K.F.; Tennant, M.E.; Dennison, C.; Robinson, N.J.; et al. BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J. Biol. Chem. 2005, 280, 17930–17937. [Google Scholar] [CrossRef] [Green Version]
- Kitazawa, M.; Cheng, D.; LaFerla, F.M. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J. Neurochem. 2009, 108, 1550–1560. [Google Scholar] [CrossRef] [Green Version]
- White, A.R.; Reyes, R.; Mercer, J.F.B.; Camakaris, J.; Zheng, H.; Bush, A.I.; Multhaup, G.; Beyreuther, K.; Masters, C.L.; Cappai, R. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 1999, 842, 439–444. [Google Scholar] [CrossRef]
- White, A.R.; Multhaup, G.; Maher, F.; Bellingham, S.; Camakaris, J.; Zheng, H.; Bush, A.I.; Beyreuther, K.; Masters, C.L.; Cappai, R. The Alzheimer’s disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 1999, 19, 9170–9179. [Google Scholar] [CrossRef] [Green Version]
- Maynard, C.J.; Cappai, R.; Volitakis, I.; Cherny, R.A.; White, A.R.; Beyreuther, K.; Masters, C.L.; Bush, A.I.; Li, Q.X. Overexpression of Alzheimer’s disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 2002, 277, 44670–44676. [Google Scholar] [CrossRef] [Green Version]
- Wang, Z.; Zhang, Y.H.; Guo, C.; Gao, H.L.; Zhong, M.L.; Huang, T.T.; Liu, N.N.; Guo, R.F.; Lan, T.; Zhang, W.; et al. Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia. Front. Aging Neurosci. 2018, 10, 9. [Google Scholar] [CrossRef] [Green Version]
- Kong, G.K.W.; Adams, J.J.; Cappai, R.; Parker, M.W. Structure of Alzheimer’s disease amyloid precursor protein copper-binding domain at atomic resolution. Acta Crystallogr. F 2007, 63, 819–824. [Google Scholar] [CrossRef] [Green Version]
- Gao, J.; Suo, C.; Tseng, J.H.; Moss, M.A.; Terry, A.V., Jr.; Chapman, J. Design and Synthesis of Ranitidine Analogs as Multi-Target Directed Ligands for the Treatment of Alzheimer’s Disease. Int. J. Mol. Sci. 2021, 22, 3120. [Google Scholar] [CrossRef] [PubMed]
- Guo, J.W.; Guan, P.P.; Ding, W.Y.; Wang, S.L.; Huang, X.S.; Wang, Z.Y.; Wang, P. Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer’s disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice. Biomaterials 2017, 145, 106–127. [Google Scholar] [CrossRef]
- Gao, H.L.; Li, C.; Nabeka, H.; Shimokawa, T.; Wang, Z.Y.; Cao, Y.M.; Matsuda, S. An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Abeta1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice. J. Alzheimers Dis. 2016, 53, 1173–1192. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Zhang, X.; Li, Y.; Zhong, M.; Zhao, P.; Guo, C.; Xu, H.; Wang, T.; Gao, H. Brain Targeting and Abeta Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP/PS1 Transgenic Mice. ACS Chem. Neurosci. 2021. [Google Scholar] [CrossRef] [PubMed]
- Nagaraj, S.; Want, A.; Laskowska-Kaszub, K.; Fesiuk, A.; Vaz, S.; Logarinho, E.; Wojda, U. Candidate Alzheimer’s Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression. Int. J. Mol. Sci. 2021, 22, 3653. [Google Scholar] [CrossRef]
- Wang, Z.; Zhang, Y.H.; Zhang, W.; Gao, H.L.; Zhong, M.L.; Huang, T.T.; Guo, R.F.; Liu, N.N.; Li, D.D.; Li, Y.; et al. Copper chelators promote nonamyloidogenic processing of AβPP via MT(1/2)/CREB-dependent signaling pathways in AβPP/PS1 transgenic mice. J. Pineal Res. 2018, 65, e12502. [Google Scholar] [CrossRef]
No. | Peptide Sequence | Frequencies of Histidine and -OH Containing Amino Acid |
---|---|---|
P-1 | VGYSGRD | 2 |
P-2 | GYWNKFD | 1 |
P-3 | HGSGVHA | 3 |
P-4 | VIPQEIF | 0 |
P-5 | EHHRSHL | 4 |
P-6 | YMNDRMY | 2 |
P-7 | APGGHSS | 3 |
P-8 | TGLIGQK | 1 |
P-9 | DKSHVGL | 2 |
P-10 | HPIKHLR | 2 |
P-11 | GTQFFNK | 1 |
P-12 a | SAQIAPH a | 2 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhang, X.; Zhang, X.; Zhong, M.; Zhao, P.; Guo, C.; Li, Y.; Xu, H.; Wang, T.; Gao, H. A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation. Int. J. Mol. Sci. 2021, 22, 6842. https://doi.org/10.3390/ijms22136842
Zhang X, Zhang X, Zhong M, Zhao P, Guo C, Li Y, Xu H, Wang T, Gao H. A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation. International Journal of Molecular Sciences. 2021; 22(13):6842. https://doi.org/10.3390/ijms22136842
Chicago/Turabian StyleZhang, Xiaoyu, Xiancheng Zhang, Manli Zhong, Pu Zhao, Chuang Guo, You Li, He Xu, Tao Wang, and Huiling Gao. 2021. "A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation" International Journal of Molecular Sciences 22, no. 13: 6842. https://doi.org/10.3390/ijms22136842